Study Shows that Many Educational Institutions Lack Broadband Support

 

 

The Minority Serving-Cyberinfrastructure Consortium, or MS-CC, recently released troubling findings regarding the state of minority-serving educational institutions in the United States.

The Consortium, along with Internet2, conducted a survey that found that Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs) and tribal colleges and universities were falling behind in terms of broadband infrastructure, workforce training and development investments.

It’s not an isolated trend, either – nearly half of the U.S.’s HBCUs and almost all tribal colleges and universities participated in the survey.

The findings are particularly concerning in the wake of the COVID-19 pandemic, which has thrust remote connectivity, broadband access, hybrid learning and more to the forefront across the world’s educational landscape.

To discuss the implications of this survey and how the U.S. might begin working to address these inequities, Voice of B2B Daniel Litwin invited Kevin Hogan, host of MarketScale’s EdTech Today, onto this Industry Update.

The duo tackled the state of connectivity, equipment, security and access to technology among these institutions, the role collaboration and engagement must play in addressing shortcomings, the need for accessible and responsible data infrastructure for campus operations, and more.

How can edtech companies encourage more deployments? What sort of national mobilization is needed to tackle compounding issues of access? Listen in to find out.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More